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ABSTRACT 
 
Aims: To evaluate the total antioxidant capacity (TAC) of Rubia cordifolia root extracts, to test 
anticancer activity against MDA-MB-231 breast cancer cell lines, and to evaluate antimicrobial 
activity of the same extract versus six Gram-positive and negative bacteria. 
Study Design:  In vitro. 
Place of Study and Duration: School of Biomedical Sciences, Ulster University, July 2014-Sept 
2015. 
Methodology: TAC was tested using ABTS, DPPH, FRAP and Folin assays and values were 
expressed as mg-gallic acid equivalents per 100 g (GAE/100 g) of sample. Anticancer properties 
were examined against MDA-MB-231 breast cancer cell lines using Sulforhodamine B assay. 
Antimicrobial activity was examined using a disk diffusion assay with three Gram-positive 
(Staphylococcus epidermidis, Staphylococcus aureus and Bacillus cereus) and three Gram-
negative (Escherichia coli, Pseudomonas aeruginosa, Salmonella typhi) bacteria.  
Results: TAC of dry extracts of Rubia cordifolia ranged from 523±43 to 4513±208 (mg GAE 
mg/100 g) depending on the method of analysis, ABTS> FRAP> Folin > DPPH methods.   
Short Research Article 
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R. cordifolia dry extract showed cytotoxicity against MDA-MB-231 with IC50 = 44 µg/ml or 5.1µM 
GAE. No antimicrobial activity was observed against the three Gram-positive, or three Gram-
negative bacterial species using the water extract or R. cordifolia. 
Conclusion: R. cordifolia aqueous extract possess high total antioxidant capacity but values 
depend on the method of analysis. R. cordifolia extract inhibits MDA-MB-231 breast cancer cells 
proliferation but nil anti-bacterial activity was observed for three Gram-positive and three Gram-
negative bacterial strains tested. 
 
 
Keywords: Manjistha; Rubia cordifolia; antioxidant; antimicrobial; MDA-MB-231; breast cancer; ABTS; 
DPPH; FRAP. 
 
1. INTRODUCTION  
 
It is a focus of the biotechnology industry to find 
solutions for hard to treat conditions like cancer 
and multiple-drug resistant bacteria. Cancer 
drugs include alkylating agents, platinum 
compounds, and antimetabolites many of which 
can cause cytotoxic damage to patients. There is 
a need for treatments, which are less harmful to 
the patient, or are beneficial when used in 
combination with established drugs [1]. The 
World Health Organisation (WHO) branded 
antibiotic resistance a major problem from 1994 
owing to a lack of new classes of antibiotics [2]. 
  
Rubia cordifolia (Manjistha, Indian madder) is a 
plant within the Rubiaceae coffee family found in 
the lower Himalayas, India, Japan, Indonesia and 
Sri Lanka [3]. Originally used as a red pigment, 
R. cordifolia is also used in Ayurvedic medicine 
to treat jaundice, joint inflammation, and cough 
[3]. R. cordifolia is gaining popularity in western 
culture as alternative therapy for skin conditions 
such as eczema, psoriasis and dermatitis [3]. 
Past investigations demonstrated that                   
R. cordifolia has significant antioxidant effects in-
vivo [4-5] and in-vitro [6-8]. Preliminary screening 
studies identified R. cordifolia as a promising 
inhibitory agent breast cancer cell proliferation 
[9,10]. The aims of this investigation were to 
evaluate the antioxidant, anticancer and 
antimicrobial activity of aqueous extracts from          
R. cordifolia within a single study. 
 
2. MATERIALS AND METHODS 
  
2.1 Preparation of the R. cordifolia 
Extracts 
  
R. cordifolia root powder (2.5 or 5 g) was stirred 
with 95ml of distilled water and the mixture 
centrifuged at 11,000 rpm for 20 minutes. The 
resulting supernatant was analysed as “whole 
powder extract”. To produce freeze-dried extract, 
the supernatant was frozen at -80ºC overnight 
and then subjected to freeze drying for 72 hours. 
The freeze-dried powder was stored in a dry 
state at room temperature until use. 
 
2.2 Determination of the Total Antioxidant 
Capacity 
 
2.2.1 Total antioxidant capacity by the FRAP 
method 
 
The Ferric Reducing Ability of Plasma (FRAP) 
assay was used to calculate the antioxidant 
power of the sample as previously described by 
Benzie and Strain [11] and further modified by 
[12]. Gallic acid solutions (1000, 500, 250, 125, 
62.5 and 0 µM) were used as calibration 
standards. R. cordifolia extract or different 
concentration of gallic acid (75 µl) and 1425 µl of 
FRAP solution were added to microcentrifuge 
tubes and the mixture stored in the dark at 37°C 
for 30 minutes. Thereafter, 200 µl of solutions 
were transferred to a 96-well microplates and 
absorbance was then recorded at 593 nm using 
a microplate reader (VERSAmax; Molecular 
devices, Sunnydale, California, USA). 
 
2.2.2 Total phenols by the Folin method  
 
The Folin method was used to determine total 
phenols as described by Singleton et al. [13]. 
Gallic acid (3000 µM, 1500 µM, 750 µM, 375 µM, 
187.5 µM, 0 M) solutions were used as reference 
antioxidant. First 50 µl of R. cordifolia extract or 
gallic acid was added to microcentrifuge tubes 
followed with 100 µl of Folin Reagent and 850µl 
of sodium carbonate (3.5%) solution. The mixture 
was stirred and incubated at 20ºC for 20 minutes 
then 200 µl of solutions were transferred to a 96-
well microplates and absorbance was then 
recorded at 760nm using a microplate reader as 
above. 
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2.2.3 Total antioxidant capacity by the DPPH 
method 
 
DPPH was used to measure the antioxidant 
capacity of R. cordifolia as previously described 
by Thaipong et al. [14]. DPPH (24 mg / 100 ml 
methanol) was stored at -20°C until required.   
For a working solution 10 ml of stock solution 
was added to 45 ml of methanol and initial 
absorbance was adjusted to 0.7. Gallic Acid 
(1000, 500, 250, 125, 62.5 and 0 µM) was used 
as standard; 75 µl of each concentration of gallic 
acid was added to an Eppendorf followed by 
1425µl of the DPPH working solution and the 
mixture was stored in the dark at 37°C for 30 
minutes. Thereafter, 200 µl of solutions were 
transferred to a 96-well microplates and 
absorbance was then recorded at 515 nm using 
a micro plate reader as above. 
 
2.2.4 Total antioxidant capacity by the ABTS 
method  
 
The modification ABTS method described by 
Walker et al. [15] was used. ABTS stock solution 
(5.00 x 10^-4 M) was created by adding 27.4 mg 
of ABTS to 90 ml of Phosphate Buffered Saline 
(PBS buffer). Sodium persulfate stock solution 
(7.4 x 10^-3 M) was created by dissolving 2 mg 
sodium persulfate in 10 ml of PBS buffer. ABTS 
working solution was created by adding 90ml of 
ABTS stock solution to 10 ml of sodium 
persulfate stock solution and storing in the dark 
for 16 hours. The initial ABTS solution was 
adjusted to give an absorbance value of 0.85 at 
734 nm using 1 cm cuvette. The ABTS assays 
was calibrated using gallic acid (1000, 500, 250, 
125, 62.5 and 0 µM) as reference. R. cordifolia 
extract or gallic acid (20 µl) was added to an 
Eppendorf followed by 1480 µl of the ABTS 
working solution and the mixture was stored in 
the dark at 37°C for 30 minutes. Thereafter 6x 
200 µl of mixtures were transferred to 
microcentrifuge tubes and absorbance recorded 
at 734 nm using a micro plate reader. 
  
2.2.5 Total antioxidant capacity calculation 
 
The total antioxidant capacity (TAC) for                  
R. cordifolia extracts determined by different 
methods (section 2.2.1-2.2.4) were expressed as 
milligram gallic acid equivalents per 100 g dry 
weight (mg-GAE/100 g) using the relation;   
  
TAC (mg-GAE/ 100 g) = 
ε′
∗  ∗ 	
  ∗
∗∗105 
where, ε’ (abs/M) = slope from the calibration 
graph, Av = Assay volume, 1500 (10-6litre), Sv = 
sample sip volume assayed, 75 (10-6 l), DF = 
Dilution factor for sample before antioxidant 
assay (DF= 1 if undiluted), Vex = original volume 
of sample extract 0.02 (l) ,FW = Formula weight of 
gallic acid; g/mole) ,W = dry weight R. cordifolia 
sample (g). 
  
2.3 Determination of Anticancer Activity 
Using Sulforhodamine B Assay 
 
MDA-MB-231 cells (American Type Cell Culture 
(ATCC) Middlesex UK) were grown in 75 cm3 
flasks till ~70-80% confluent,  rinsed three times 
using sterile PBS and trypsinized for 5 minutes at 
37°C to detach cells from the flask.  Cells were 
transferred to microplate (10,000 cells/50 µl/ 
well) and incubated for 24 hours at 37°C to allow 
adherence.  Prior to cytotoxicity testing, 20 mg 
Rubia cordifolia extract was dissolved in 4 ml 
DMEM media and passed through a 0.2 micron 
syringe filter. Sterile R. cordifolia extract was 
serially diluted (5, 1. 0.2, 0.04, 0.008 mg/ml) and 
50 µl added to cells followed by incubation at 
37°C for 72 hours. The negative control involved 
adding 50µl of DMEM to cells. Tests were 
repeated on three separate occasions with 6 
treatments at each concentration.  
 
Sulforhodamine (SRB) was performed according 
to the method described in [16], and absorbance 
was read at 525 nm. Cell viability (CV%) was 
calculated from the expression CV(%) = 
(100*[(A-B)/(A0 –B)] where A=absorbance of 
cells treated with extract, A0 = absence from cells 
treated with vehicle/ media, B= absorbance 
readings for blank microplate wells lacking cells 
or vehicle treatment. The 50% inhibitory 
concentration for extract (IC50) was determined 
by linear regression of CV(%) plotted versus log. 
DrugConc (Y = mx + C). From graphing CV(%) = 
m. (logDrugConc) + C, then log (IC50) = (50 – 
C)/ m.  In addition IC50 (µg/ml) was translated to 
total phenols equivalent (mol-GAE / l) using the 
relation: IC50 (mol-GAE / l) = IC50(g/l)* Total-
phenols (mgGAE/g) *(1/170.12). 
 
2.4 Determination of the Antimicrobial 
Activity by Disk Diffusion 
 
The disk diffusion method was performed                    
as outlined by Fiebelkorn et al. [17] with                  
slight modifications. Three Gram-positive 
(Staphylococcus aureus, Staphylococcus 
epidermidis and Bacillus cereus) and                      
three Gram-negative (Escherichia coli, 
  
 
 
Barlow et al.; JABB, 5(1): 1-8, 2016; Article no.JABB.22625 
 
 
 
4 
 
Pseudomonas aeruginosa and Salmonella typhi) 
bacteria were grown on agar plates and 
confirmed by Gram staining. A few colonies were 
removed from the agar plate using a sterilised 
loop and inoculated into 15 ml nutrient broth and 
incubated at 37°C for 24 hours to allow growth. 
After 24 hours 200 µl of the inoculated broth was 
pipetted onto an agar plate and spread evenly 
using a sterile spreader and briefly allowed to 
dry. Antibiotic disks (streptomycin, penicillin G 
and amoxicillin used as positive controls) and 
two blank paper disks were added to each agar 
plate. R. cordifolia dry extract solubilised in PBS 
was added to one of the blank disks in 
concentrations from 62.5 µg per disk to 1000 µg 
per disk to determine minimum inhibitory 
Concentration. 20 µl of PBS was added to the 
final blank disk as a negative control. Disks were 
added the agar plates followed by incubation at 
37°C for 24 hours. The diameters of the zones of 
inhibition in mm were measured using a ruler. 
This procedure was carried out under sterile 
conditions via Bunsen burner or sterilised laminar 
flow cabinet.  
 
2.5 Statistical Analysis 
 
All methods were conducted in triplicate and the 
average of these results is displayed in the 
relevant figures/tables with ± Standard Deviation 
(SD). To assess the statistical significance 
between the whole plant powder and dry extract 
values the independent t-test and Mann-Whitney-
U test was performed. To compare the statistical 
significance of the means between each 
concentration used in the Sulforhodamine B 
assay to that of the negative control, the One-
Way ANOVA test was used. For these tests an 
alpha value of (P=0.05) was considered 
significant. IBM SPSS statistics software, version 
22, was used to conduct the statistical analysis.    
 
3. RESULTS AND DISCUSSION 
 
3.1 Total Antioxidant Capacity 
 
Aqueous extracts from R. cordifolia 2.5-5 g of 
powder per 100 g of solvent were prepared with 
a yield of 13% w/v. From Table 1 the total 
phenols content for the freshly prepared and 
freeze dried water extract from R. cordifolia were 
0.23% (w/w) and 1.95% (w/w) by comparison 
with 2.11 (w/w) reported previously for a dried 
extract [6-7]. The total phenol values for water 
extracts from R. cordifolia were lower than some 
total phenols values for reported for common 
teas and similar to others [12]; green tea (11.9% 
w/w), black tea (9.2% w/w), white tea (8.5% 
w/w), rooibos tea (2.8% w/w) and apple tea 
(1.76% w/w). Previous investigations suggested 
that the TAC of R. cordifolia root extracts were 
determined by hydroxyanthraquinones [3,7]. 
 
The total phenols values for R. cordifolia 
produced with a variety of solvents are shown in 
Fig. 1. Dimethyl sulfoxide (DMSO) was an 
efficient extracting agent and isopropanol, ethyl 
acetate and cyclohexane were less effective. 
Currently, it is not certain whether the 
composition of extracts produced using different 
solvents are similar or otherwise. In this 
preliminary study, the focus was on samples 
produced using water extraction, either freshly 
prepared or freeze dried. 
 
3.2 Anticancer Properties 
 
R. cordifolia water extract showed cytoxcity 
towards breast cancer cell line MDA-MB-231 
compared to a negative control treated with 
DMEM media (Figs. 2 and 3). From Fig. 2, the 
concentration of extract leading to 50% inhibition 
of cells (IC50) was 286 µg/ ml and 43 µg/ml for 
24 hrs or 72 hrs treatment with freshly prepared 
R. cordifolia extract. Therefore, R. cordifolia was 
more cytotoxic after 72 hrs treatment as 
compared to a 24 hr treatment. Close 
examination of Fig. 2 shows cell numbers had 
increased by 2-fold during 72 hr compared to 
24hr treatment and R. cordifolia could reduce cell 
growth as well as causing cell death (reductions 
in cell numbers). From Fig. 3, the cytoxcity of 
freeze dried R. cordifolia aqueous extracts 
yielded an IC50 value of 45 µg/ ml, which is 
similar to results using freshly prepared water 
extracts and 72 hrs treatment (Fig. 2). In 
summary these 72 hr tests suggest an average 
IC50 value of 44 µg/ ml for R. cordifolia extract; 
the corresponding total phenols concentration is 
5.1x10-6M GAE. The findings of the present 
study support previous R. cordifolia screening 
results for four human breast cancer cells lines 
[9,10] as well as other cell lines [17,18]. 
Campbell et al. [9] examined the effect of 71 
Chinese medicinal herbs on four human breast 
cancer lines and identified R. cordifolia as one of 
the promising agents for future study also 
confirmed by Shoemaker et al. [10]. 
 
Previous screening studies did not report dose-
response profiles or IC50 values for R. cordifolia 
applied to MDA-MB-231 cells [9,10]. 
Interestingly, the IC50 was 100 µg/ml for MCF-7 
cells treated with R. cordifolia extract [9] and 
486-1000 µg/ml for other herbal agents [10]. 
R. cordifolia root extracts prepared with 
methanol, petroleum ether or dichloromethane 
yielded IC50 values of 12-29 µg/ml for Hep 2G 
cells and 23-49 µg/ml for Hela cells [17]. 
Anthraquinones from R. cordifolia are believed to 
be responsible for anticancer activity but IC50 
values seem not yet available. A major 
anthraquinones from rhubarb roots tested with 
MDA-MB-231 cells produced an IC50 value of 16 
µg/ml (60 µM) [18]. R. cordifolia 
thought to promote cell apoptosis via a caspase 
dependent route as well as causing cell cycle 
arrest [9,19]. 
Table 1. Characteristics of antioxidant assays and the total antioxidant capacity for 
Assay a LDR (µM) ε (M cm
FRAP 0-25 195014
DPPH 0-25 92886
Folin 0-75 25836
ABTS 0-20 50642
aResults from 3-experiments, n >48 data points, RCFE = R. cordifolia fresh extract, RCFD =R. cordifolia
dried extract,*LDR =Range of concentrations or which calibration graph is straight, 
absorptivity, R2 = correlation coefficient. 
weight), bWithin each column all TAC a
for microplate reader pathlength of 0.5 cm [12]
Table 2. Summary of the disk diffusion results
 Streptomycin 
(2.5 µg) 
B. cereus 24±1 
P. aeruginosa  19±1.1 
S. typhi 28±1 
E. coli 24±0.8 
S. epidermidis 23±1.4 
S. aureus 20±1 
Measurements are average zones of Inhibition from three replicates ± SD and include the size of the paper disk 
(6mm).  RCFD = Freeze dried R. cordifolia extract, Phosphate Buffered Saline (PBS) was used as a negative 
control. Antibiotics were used as a pos
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extracts are 
3.3 Antimicrobial Activity 
 
In this study, the antimicrobial activity of 
R. cordifolia aqueous freeze dried extract was 
analysed using the Kirby-Bauer disk diffusion 
test.  Table 2 shows that R. cordifolia
(62.5 µg – 1 mg per disk) did not produce a 
of clearance with any bacterial strain examined. 
PBS vehicle for R. cordifolia extract produced nil 
results. By contrast, streptomycin, amoxicillin and 
penicillin G used as positive controls showed 
antibacterial effects with streptomycin having a 
strong effect against each bacterial strain.
 
R. cordifolia aqueous extract 
 
-1)* R2 TAC ‡ (RCFE)b TAC
 0.9829 159±11 2508±
 0.999 63±4 523±
 0.9987 235±59 1954±
 0.995 601±13 4513±
ε (M cm
‡Total antioxidant capacity (TAC) expressed as mg-GAE/100g dry 
re significantly different at (P=0.05).*Calibration graph gradient corrected 
 
 
 
 
Amoxicillin  
(1 µg) 
Penicillin 
G (1 µg) 
RCGF 
(62.5 µg) 
RCFD
(1
13±0.4 6 6 6 
6 6 6 6 
22±1.2 16±2.8 6 6 
13±0.8 6 6 6 
6 6 6 6 
12±0.8 6 6 6 
itive control. Treatment time was 24 hours
 
R. cordifolia extracts using different solvents
g-GAE per 100 g of dried extract 
 
 
 
 
no.JABB.22625 
 
 
                    
 extract 
zone 
 
 
‡(RCFD) 
95 
43 
417 
208 
 freeze 
-1) = molar 
 
 mg) 
PBS    
6 
6 
6 
6 
6 
6 
 
 
 Fig. 2. Anticancer activity of fresh aqueous 
Anticancer activity evaluated using MDA
Y-axis shows bar-chart for cell number (%) referenced at 24
inhibition (% inh) for 24 hr or 72 hrs. Mean results are for three experiments (n=18) for each treatment with ± 
SEM. The 50% inhibitory concentration (IC50) occurs at 43
 
Fig. 3. Anticancer activity of freeze dried 
Anticancer activity evaluated using MDA
determined by Sulforhodamine B staining. Data shows mean results from three experiments (n=18) for each 
treatment with ± SEM. ***Show significant difference between treatments and vehicle control (P =0.05). 
The 50% inhibitory concent
  
Previous investigations by Basu et al
that methanol and chloroform extracts from 
R. cordifolia (1–10 mg/mL; 0.1-1 mg /disk) were 
effective against Gram-positive bacteria and 
inactive for Gram-negative strains, with exception 
of P. aeruginosa. In agreement with present 
findings, water extracts of R. cordifolia
inactive with most Gram-negative strains. The 
Gram-positive strains, B. subtilis and 
were affected by water extract of 
[20] but this result is not supported by this study. 
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R. cordifolia root extract measure
Sulforhodamine B assay 
-MB-231 breast cancer cells. Treatment time was 24 hrs or 72
 hr results. Right Y-axis shows (line drawing) % 
 µg/ml (72 hr treatment) or 286 ug/ ml 
(24 hr treatment) 
R. cordifolia root extract measured by the 
Sulforhodamine B assay 
-MB-231 breast cancer cells. Treatment time was 72 hours
ration (IC50) occurs at 45 µg/ml 
. [20], found 
                 
 were 
S. aureus 
R. cordifolia 
The preliminary studies using extracts prepared 
with DMSO or isopropanol showed some activity 
for P. aeruginosa and S. epidermis
shown). It has been suggested that solvent 
choice has a large effect on the antimicrobial 
characteristic of R. cordifolia [20].  
 
4. CONCLUSION 
 
R. cordifolia aqueous extract shows significant 
antioxidant capacity as measured by four 
 
 
 
 
no.JABB.22625 
 
 
d by the 
 hrs. Left 
 
 
. Viability was 
 
 (data not 
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common antioxidant assays but results depend 
on the assay used: ABTS > FRAP > Folin > 
DPPH method.  Tests using MDA-MB-231 breast 
cancer cell line showed R. cordifolia produced a 
dose-dependent inhibition of cell proliferation 
with IC50 of 44 µg /ml compared with ~16 µg /ml 
reported for purified anthraquinones. However,  
the water extract from R. cordifolia showed no 
antimicrobial activity using a standardized disk 
diffusion assay at concentrations of 1 mg per 
disk and it may be concluded, that effective 
doses for in-vitro anticancer activity of R. 
cordifolia is lower  compared to doses required 
for anti-microbial activity. Future studies are 
envisaged to explore the effect solvent choice on 
the characteristics of R. cordifolia extracts.   
 
COMPETING INTERESTS 
 
Authors have declared that no competing 
interests exist. 
 
REFERENCES 
 
1. Johnstone RW. Histone-deacetylase 
inhibitors: Novel drugs for the treatment of 
cancer. Nat Rev Drug Discov. 2002;1(4): 
287-99.  
PMID: 12120280  
2. Kumarasamy KK, Toleman MA, Walsh TR, 
Bagaria J, Butt F, Balakrishnan R, 
Chaudhary U, et al. Emergence of a new 
antibiotic resistance mechanism in India, 
Pakistan and The UK: A molecular, 
biological and epidemiological study. 
Lancet Infect Dis. 2010;0(9):597-602. 
PMID: 20705517 
3. Kannan M, Singh AJA., Narayanan M. 
Phytochemistry and ethano-
pharmacological studies on Rubia 
cordifolia Linn. (Rubiaceae). 
Ethnobotanical Leaflets. 2009;2009(2):9. 
4. Tripathi YB, Shukla S, Sharma M, Shukla 
VK. Antioxidant property of Rubia-cordifolia 
extract and its comparison with vitamin-E 
and parabenzoquinone. Phytother Res. 
1995;9(6):440-443.  
PMID: 9425750. 
5. Rawal A, Muddeshwar M, Biswas S. Effect 
of Rubia cordifolia, Fagonia cretica linn, 
and Tinospora cordifolia on free radical 
generation and lipid peroxidation during 
oxygen-glucose deprivation in rat 
hippocampal slices. Biochem Biophys Res 
Comm. 2004;324(2):588-596.  
PMID: 15474468. 
6. Cai Y, Luo Q, Sun M, Corke H. Antioxidant 
activity and phenolic compounds of 112 
traditional Chinese medicinal plants 
associated with anticancer. Life Sci. 
2004;74(17):2157-2184.  
PMID: 14969719. 
7. Cai Y, Sun M, Xing J, Corke H. Antioxidant 
phenolic constituents in roots of Rheum 
officinale and Rubia cordifolia: Structure-
radical scavenging activity relationships. J 
Agric Food Chem. 2994;52(26):7884-7890. 
PMID: 15612771. 
8. Surveswaran S, Cai YZ, Corke H, Sun M. 
Systematic evaluation of natural phenolic 
antioxidants from 133 Indian medicinal 
plants. Food Chem. 2007;102(3):938-953. 
9. Campbell MJ, Hamilton B, Shoemaker M, 
Tagliaferri M, Cohen I, Tripathy D. 
Antiproliferative activity of Chinese 
medicinal herbs on breast cancer cells             
in vitro. Anticancer Res. 2002;22(6C):         
3843-52.  
PMID: 12553004. 
10. Shoemaker M, Hamilton B, Dairkee SH, 
Cohen I, Campbell MJ. In-vitro anticancer 
activity of twelve Chinese medicinal herbs. 
Phytother Res 2005;19(7):649-51.  
PMID: 16161030 
11. Benzie IF, Strain JJ. The ferric reducing 
ability of plasma (FRAP) as a measure of 
antioxidant power: The FRAP assay. Anal. 
Biochem. 1996;239(1):70-76.  
PMID: 8660627 
12. Wong C, Cheung WSM, Lau YY, Bolanos 
de la Torre, AAS, Owusu-Apenten RK. A 
FRAP assay at pH 7 unveils extra 
antioxidant activity from green, Blank, 
White and Rooibos Tea but not Apple Tea; 
2015. 
Available:http://verizonaonlinepublishing.co
m/FnNPDF/FoodandNutritionReport3.pdf  
(Retrieved Sept, 2015). 
13. Singleton VL, Orthofer R, Lamuela-
Raventos RM. Analysis of total phenols 
and other oxidation substrates and 
antioxidants by means of Folin-Ciocalteu 
reagent. Methods Enzymol. 1999;299C: 
152-178. 
14. Thaipong K, Boonprakob U, Crosby K, 
Cisneros-Zevallos L, Byrne DH. 
Comparison of ABTS, DPPH, FRAP and 
ORAC assays for estimating antioxidant 
activity from guava fruit extracts. J Food 
Compost Anal. 2006;19(6):669-675. 
15. Walker RB, Everette JD. Comparative 
reaction rates of various antioxidants with 
  
 
 
Barlow et al.; JABB, 5(1): 1-8, 2016; Article no.JABB.22625 
 
 
 
8 
 
ABTS radical cation. J Agric Food Chem. 
2009;57(4):1156-1161. 
16. Vichai, V, Kirtikara K. Sulforhodamine B 
colorimetric assay for cytotoxicity 
screening. Nat Protoc. 2006;1(3):          
1112-1126.  
PMID: 17406391 
17. Fiebelkorn KR, Crawford SA, McElmeel 
ML, Jorgensen JH. Practical disk diffusion 
method for detection of inducible 
clindamycin resistance in Staphylococcus 
aureus and coagulase-negative 
staphylococci. J Clin Microbiol. 2003; 
41(10):4740-1744.  
PMID: 14532213 
18. Patel PR, Nagar AA, Patel RC, Rathod 
DK, Patel VR. In-vitro anticancer activity of 
Rubia cordifolia against Hela and Hep-2 
cell lines. Phytomedicine. 2010;2:44-46. 
19. Zhang L, Chang CJ, Bacus SS, Hung           
MC. Suppressed transformation and               
induced differentiation of HER-2/neu-
overexpressing breast cancer cells                  
by emodin. Cancer Res 1995;55(17):             
3890-3896.  
20. Tiwari S, Upadhyaya R, Shroti R, 
Upadhyaya ST. Rubia cordifolia root 
extract induces apoptosis in cancer cell 
line. Sci Secure J Biotech. 2012;1(2):             
39-42. 
21. Basu S, Ghosh A, Hazra B.  Evaluation of 
the antibacterial activity of Ventilago 
madraspatana Gaertn., Rubia cordifolia 
Linn. and Lantana camara Linn.: Isolation 
of emodin and physcion as active 
antibacterial agents. Phytother Res. 
2005;19(10):888-894. 
_________________________________________________________________________________ 
© 2016 Barlow et al.; This is an Open Access article distributed under the terms of the Creative Commons Attribution License 
(http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, 
provided the original work is properly cited. 
 
 
 
 
Peer-review history: 
The peer review history for this paper can be accessed here: 
http://sciencedomain.org/review-history/12260 
